Concepedia

Elizabeth Witten

EW

9

Publications

753

Citations

9

H-Index

1997

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Broad Institute

Instytut Hematologii i Transfuzjologi

Elizabeth Witten is an author at Harvard University specializing in medicine, vaccination, and vaccine development.

ORCID

Top concepts

Publications per year

1997–2022

9

Publications

9

Regulation of the <i>Saccharomyces cerevisiae HOG1</i> Mitogen-Activated Protein Kinase by the <i>PTP2</i> and <i>PTP3</i> Protein Tyrosine Phosphatases

Susannah M. Wurgler‐Murphy, Tatsuya Maeda, Elizabeth Witten et al. · Molecular and Cellular Biology · 1997 · 267 citations · Full text

Regulation of MTK1/MEKK4 Kinase Activity by Its N-Terminal Autoinhibitory Domain and GADD45 Binding

Hiroaki Mita, Jun‐ichiro Tsutsui, Mutsuhiro Takekawa et al. · Molecular and Cellular Biology · 2002 · 152 citations · Full text

Requirement of STE50 for Osmostress-Induced Activation of the STE11 Mitogen-Activated Protein Kinase Kinase Kinase in the High-Osmolarity Glycerol Response Pathway

Francesc Posas, Elizabeth Witten, Haruo Saito · Molecular and Cellular Biology · 1998 · 138 citations · Full text

A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation

Grégory Lazarian, Shanye Yin, Elisa ten Hacken et al. · Cancer Cell · 2021 · 55 citations · Full text

, , +12

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

Masayasu Naito, Ursula Hainz, Ute Burkhardt et al. · Cancer Immunology Immunotherapy · 2012 · 37 citations · Full text

Rows per page

1–5 of 9